CPHCipher Pharmaceuticals Inc.TSXHealth Care
C$13.39−C$0.26Down1.90%Oct 26, 2026 close
Coming Soon
Format:
METRIC
TTM
Dec 25
Dec 24
Dec 23
Period Ending—Dec 31, 2025Dec 31, 2024Dec 31, 2023
Revenue
Revenue$49.6M$50.5M$33.4M$21.2M
Cost of Revenue$9.23M$10.0M$9.26M$4.07M
Gross Profit$40.4M$40.4M$24.1M$17.1M
Operating
Operating Income$19.7M$16.9M$7.85M$10.3M
EBITDA$26.9M$24.1M$11.9M$11.5M
Pre-Tax Income$17.5M$17.2M$2.96M$12.7M
Income Tax Expense-$11.5M-$10.2M-$8.59M-$7.70M
Net Income$29.0M$27.3M$11.5M$20.4M
Per Share
EPS (Basic)$1.14$1.07$0.47$0.82
EPS (Diluted)$1.11$1.05$0.46$0.80
Shares Basic25.5M25.5M24.7M25.0M
Shares Diluted26.1M26.0M25.2M25.4M
Dividend Per Share————
Margins
Gross Margin+81.4%+80.1%+72.2%+80.8%
EBIT Margin+39.8%+33.4%+23.5%+48.7%
EBITDA Margin+54.3%+47.8%+35.6%+54.5%
Net Margin+58.4%+54.2%+34.6%+96.3%
Effective Tax Rate-66.0%-59.2%-290.7%-60.7%
Growth
Revenue Growth—+51.2%+57.7%+2.4%
Net Income Growth—+136.7%-43.4%-23.5%
EPS Growth—+128.3%-42.5%-22.3%
Share Count Change—+3.0%-0.8%-1.5%
Free Cash Flow
Free Cash Flow$26.0M$29.5M$19.5M$16.0M
FCF Per Share$1.00$1.14$0.77$0.63
FCF Margin+52.5%+58.5%+58.5%+75.5%
FCF Growth—+51.4%+22.1%+50.1%
© 2026 WallStMonk. All rights reserved. v0.19.39Not investment advice · Data as of previous market close